Advanced health intelligence obtains overseas r&d reimbursement under australia's research and development tax incentive scheme (r&dti)

South perth, australia--(newsfile corp. - august 17, 2023) -  advanced health intelligence ltd (asx: ahi) (nasdaq: ahi) ("ahi" or the "company") is pleased to announce a significant milestone in its ongoing commitment to innovation and research. ahi's submission to the australian government was successful in obtaining eligibility for 43.5% reimbursement of approved expenditures incurred abroad for overseas research & development (r&d) of intellectual property (ip) under the australian government research and development tax incentive scheme.
AHI Ratings Summary
AHI Quant Ranking